QPPV.COM KNOWLEDGE ASSESSMENT

Listedness, Expectedness and Reference Safety Information

Test your understanding of the concepts covered by Listedness, Expectedness and Reference Safety Information.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A QC review finds frequent manual changes from “expected” to “unexpected” because the system matches broad label terms without considering severity. What is the most appropriate quality response?
Question 2 of 10 Which statement correctly distinguishes seriousness, expectedness and causality?
Question 3 of 10 Which statement best describes the relationship between a CCDS and a CCSI?
Question 4 of 10 A local label lists a mild, self-limited rash. A case describes a severe blistering mucocutaneous syndrome. What is the best approach to expectedness assessment?
Question 5 of 10 A product label mentions an adverse reaction associated with the pharmacological class but does not establish it as a reaction for the individual product. How should the assessor treat that information?
Question 6 of 10 The local product information describes a reaction but does not indicate that it may be fatal. An ICSR reports that reaction with a fatal outcome. What does the article say about post-authorisation unexpectedness under ICH E2D(R1)?
Question 7 of 10 A multinational clinical trial uses nationally authorised products whose SmPCs differ. What approach does the article describe for selecting the trial reference?
Question 8 of 10 For periodic reporting of a marketed product under ICH E2C(R2), which reference is ordinarily used to classify reactions as listed or unlisted?
Question 9 of 10 Which record set would best support reconstruction of a case-level expectedness or listedness decision during an inspection?
Question 10 of 10 A case's coded Preferred Term appears in the local label, but the reported diagnosis and outcome describe a clinically distinct, more severe syndrome. What is the most appropriate assessment principle?

Select an answer to continue.

QPPV.com